Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03590171
Title International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Charite University, Berlin, Germany
Indications

B-cell acute lymphoblastic leukemia

T-cell acute lymphoblastic leukemia

Therapies

Bortezomib

Age Groups: child
Covered Countries


No variant requirements are available.